On January 10th, Zhuzhou CRRC Times Electric (03898) spent 23.5329 million Hong Kong dollars to repurchase 78.85 thousand shares.
Era Electric (03898) announced that on January 10, 2025, the company will invest 23.529 million Hong Kong dollars...
Zhuzhou CRRC Times Electric (03898) announced that on January 10, 2025, the company will spend 23.5329 million Hong Kong dollars to repurchase 78.85 thousand shares at a repurchase price of 29.50-30.35 Hong Kong dollars per share.
Related Articles
.png)
HENLIUS (02696): The phase I clinical trial of HLX48 (an antibody drug conjugate targeting EGFR and c-MET for the treatment of advanced/metastatic solid tumors) for injection has been approved to be conducted in Australia.
KML TECH (08065) terminates stock incentive plan.
HAOHAI BIOTEC (06826) spent 703,300 Hong Kong dollars on May 13 to repurchase 31,500 shares.
HENLIUS (02696): The phase I clinical trial of HLX48 (an antibody drug conjugate targeting EGFR and c-MET for the treatment of advanced/metastatic solid tumors) for injection has been approved to be conducted in Australia.
KML TECH (08065) terminates stock incentive plan.
HAOHAI BIOTEC (06826) spent 703,300 Hong Kong dollars on May 13 to repurchase 31,500 shares.
RECOMMEND
Two Mainland Accounting Firms Approved for H‑Share Audits, Lowering Listing Costs and Deepening Mainland–Hong Kong Market Integration**The Ministry of Finance, the CSRC, and Hong Kong’s Accounting and Financial Reporting Council have approved two additional mainland accounting firms—RSM China and ShineWing—to conduct H‑share audit work, marking the first expansion of the list since 2010.
11/05/2026
HKEX Tightens Rules on Auditor Dismissals as Sudden “Audit Firm Switches” Raise Governance Concerns
11/05/2026
The Chip Stock Frenzy Is Still Accelerating
11/05/2026
